Publications 2024

Cochrane reviews - published

  1. Pessano S, Gloeck NR, Tancredi L, Ringsten M, Hohlfeld A, Ebrahim S, Albertella M, Kredo T, Bruschettini M. Ibuprofen for acute postoperative pain in children.  Cochrane Database of Systematic Reviews 2024, Issue 1. Art. No.: CD015432
  2. Ng G, Bruschettini M, Ibrahim J, da Silva O. Inhaled bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews 2024, Issue 4. Art. No.: CD003214
  3. Constantin AM, Noertjojo K, Sommer I, Pizarro AB, Persad E, Durao S, Nussbaumer-Streit B, Sampson O, Rhodes S, Fletcher T, Martin C, McElvenny DM, Jørgensen KJ, Bruschettini  M. Workplace interventions to reduce exposure to SARS-CoV-2 infection outside of healthcare settings. Cochrane Database of Systematic Reviews 2024, Issue 4. Art. No.: CD015112
  4. Sibrecht G, Wróblewska-Seniuk K, Bruschettini M. Noise or sound reduction management in the neonatal intensive care unit for preterm or very low birth weight infants. Cochrane Database of Systematic Reviews 2024, Issue 4. Art. No.: CD010333
  5. Urru S, Geist M, Carlinger R, Bodrero E, Bruschettini M. Strategies for cessation of caffeine administration in preterm infants. Cochrane Database of Systematic Reviews 2024, Issue 7. Art. No.: CD015802
  6. Sibrecht G, Wong MY, Shrestha R, Bruschettini M. Acupuncture for hypoxic ischemic encephalopathy in neonates. Accepted for publication, October 2024
  7. Cagnotto G, Juhl CB, Ahlström F, Wikström F, Bruschettini M, Petersson I, Dreyer L, Compagno M. TNF-alpha inhibitors for juvenile idiopathic arthritis. Accepted for publication, October 2024
  8. Morag I, Xiao Y, Bruschettini M. Cycled light in the intensive care unit for preterm and low birth weight infants. Accepted for publication, October 2024
  9. Cagnotto G, Compagno M, Scire CAlberto, Stróżyk A, Bruschettini M. Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis. Accepted for publication, November 2024

 

Cochrane reviews - submitted

  1. Urlesberger B, Cabano R, Soll G, Oei JL, Pahl A, Schmölzer GM, Bruschettini M. Acupuncture for neonatal abstinence syndrome in newborn infants. Cochrane Database of Systematic Reviews. Submitted December 2023
  2. King E, Horn D, Gluchowski N, Bruschettini M, Fiander M, Soll R, O'Reilly D. Safety and efficacy of proton pump inhibitors in preterm infants with gastroesophageal reflux disease. Submitted January 2024
  3. Färnqvist K, Bruschettini M, Olsson E, Garratt A, Paraskevas T, Soll R, Persad E. Clinical rating scales for assessing pain in newborn infants. Submitted April 2024
  4. Cabano R, Abdallat  H, Abuhammour R, Soll G, Oei JL, Schmölzer GM, Bruschettini M. Acupuncture for procedural pain in newborn infants. Submitted April 2024
  5. Darlison P, Moresco L, Bruschettini M, Nussbaumer-Streit B, Gisselsson-Solen M. Decongestants and antihistamines for acute otitis media in children. Submitted October 2024
  6. Bruschettini M, Moberg T, O'Donnell CP, Davis PG, Morley CJ, Moja L, Calevo MG. Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes. Submitted October 2024

 

Cochrane reviews in preparation:

  1. Kinoshita M, Del Giovane C, Borys F, Mitra S, Hall R, Wróblewska-Seniuk K, Soll R, Bruschettini M. Methylxanthine for preventing morbidity and mortality in preterm infants: a network meta-analysis. Cochrane Database of Systematic Reviews 2023, Issue 12. Art. No.: CD015058
  2. Olsson E, Sibrecht G, Conde-Agudelo A, Díaz-Rossello JL, Ehret D, Bruschettini M. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants
  3. Romantsik O, Sharifan A, Fiander M, Ng E, Bruschettini M. Midazolam for sedation of infants in the neonatal intensive care unit
  4. Bodrero E, Isaza Lopez MC, Greisen G, Gluud C, Bruschettini M. Cerebral near-infrared spectroscopy monitoring for prevention of brain injury in very preterm infants
  5. Borys F, Sibrecht G, Wróblewska-Seniuk K, Magagnoli C, Fiander M, Ringsten M, Bruschettini M. Indications for caffeine initiation in preterm infants.
  6. Urru S, Geist M, Carlinger R, Bodrero E, Giordano P, Bruschettini M. Strategies for cessation of caffeine administration in preterm infants. Update 2025
  7. O'Reilly D, Fiander M, Bruschettini M, Soll R. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Update 2025

 

Cochrane protocols - published

  1. Wróblewska-Seniuk K, Lenells M, Prescott Glenton M, Fiander M, Soll R, Bruschettini M. Multisensorial stimulation for promoting development and preventing morbidity in preterm infants. Cochrane Database of Systematic Reviews 2024, Issue 7. Art. No.: CD016073
  2. Lenells M, Prescott Glenton M, Wróblewska-Seniuk K, Fiander M, Soll R, Bruschettini M. Olfactory stimulation for promoting development and preventing morbidity in preterm infants. Cochrane Database of Systematic Reviews 2024, Issue 8. Art. No.: CD016074
  3. Prescott Glenton M, Wróblewska-Seniuk K, Lenells M, Fiander M, Soll R, Bruschettini M. Vestibular stimulation for promoting development and preventing morbidity in preterm infants. Cochrane Database of Systematic Reviews 2024, Issue 9. Art. No.: CD016072
  4. Nissimov S, Sibrecht G, Weerasekara I, Bartocci M, Bruschettini M. Minimizing blood sampling in preterm infants. Cochrane Database of Systematic Reviews 2024, Issue 11. Art. No.: CD016077
  5. Bodrero E, Isaza C, Fiander M, Soll R, Bruschettini M. Methylxanthines for the prevention or treatment of intermittent hypoxemia or respiratory insufficiency in late preterm infants. Cochrane Database of Systematic Reviews 2024, Issue 11. Art. No.: CD016113
  6. Wróblewska-Seniuk K, Wallman-Stokes A, Edwards E, Fiander M, Bruschettini M, Soll R,. Financial incentives for family members of hospitalized neonates for improving family engagement. Accepted for publication, October 2024
  7. Prescott Glenton M, Geist M, Olsson E, Fiander M, Soll R, Bruschettini M. Infant positioning for promoting development and preventing morbidity in preterm infants. Accepted for publication, October 2024
  8. Borys F, Prescott Glenton M, Fiander M, Soll R, Bruschettini M. Clustering of nursery care activities for promoting development and preventing morbidity in preterm infants. Accepted for publication, October 2024
  9. Olsson E, Prescott Glenton M, Titlestad KBerg, Fiander M, Soll R, Bruschettini M. Individualized developmental care interventions for promoting development and preventing morbidity in preterm infants. Accepted for publication, November 2024

Cochrane protocols - submitted

  1. Pessara S, Boldor M, Faravelli F, Fiander M, Jørgensen KJ, Soll RF, Bruschettini M. Next-Generation Sequencing (NGS) techniques for pre-symptomatic identification of genetic diseases in newborns. Submitted June 2024
  2. Weerasekara I, Styrmisdóttir L, Ringsten M, Orsini N, Andersson O, Mukiira C, Sharma S, Fiander M, Andersson A, Vaag A, Nilsson PM, Bruschettini M. The effect of birth weight and prematurity on the incidence of type 2 diabetes mellitus: a dose-response meta-analysis of observational studies. Submitted June 2024
  3. Olsson E, Romantsik O, Lundgren P, Fiander M, Snellman A, Hellstrom A, Bruschettini M. Pain management for screening or treatment of retinopathy of prematurity. Submitted September 2024
  4. Badura A, Hiekel J, Saladino A, Murature D, Wellmann S, Fiander M, Bruschettini M. Motor interventions initiated prior hospital discharge to prevent neurodevelopmental impairment in preterm infants. Submitted September 2024
  5. Badura A, Faas D, Gabriel A, Wellmann S, Cracknell J, Fiander M, Soll R, Bruschettini M. In-hospital motor interventions to prevent neurodevelopmental impairment in preterm infants: a scoping review. Submitted October 2024
  6. Bäcke P, Thernström Blomqvist Y, Björk M, Fiander M, Soll R, Bruschettini M. Training to increase parental participation in care decisions and delivery for infants in neonatal units. Submitted October 2024
  7. Bruschettini M, Sibrecht G, Mohammad Khuzaini A, Fiander M, Soll R. Higher initial doses of surfactant for the prevention or treatment of respiratory distress syndrome in preterm infants. Submitted October 2024
  8. Cagnotto C, Bäcklund R, Bengtsson A, Bruschettini M. Immunosuppressants and immunomodulators for IgG4-related disease. Submitted November 2024

Cochrane protocols in preparation:

  1. Bolanos L, Pahl A, Fiander M, Cracknell J, Gautham KS, Soll R, Bruschettini M. Intratracheal instillation of corticosteroids using surfactant as a vehicle for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome
  2. Darlison P, Bruschettini M, Gisselsson-Solén M, Jenniskens K, Hooft L. Artificial intelligence for diagnosing acute otitis media. 
  3. Wróblewska-Seniuk K, Arham M, Geist M, Björklund M, Rose CJ, Sibrecht G, Borys F, Bruschettini M. Neonatal morbidity in late preterm and early term infants 
  4. Garegnani L, Escobar Liquitay CM, Esteban I, Russo C, Bruschettini M, Franco J. Monoclonal antibodies for preventing respiratory syncytial virus infection in children. A network meta-analysis. 
  5. Sotiropoulos J, Seidler L, Fiander M, Bruschettini M,Soll R. Delivery room oxygen titration strategies to improve preterm infant outcomes
     

 

Peer-reviewed articles in other Journals

  1. Björklund M, Ringsten M, Bruschettini M, Garwicz M. Teaching evidence-based medicine by using a systematic review framework: implementation in a Swedish university setting. BMJ EBM, Online First: 27 March 2024. doi: 10.1136/bmjebm-2023-112607
  2. Romantsik O, Bank M, Menon JML, Malhotra A, Bruschettini M. Value of preclinical systematic reviews and meta-analyses in pediatric research. Pediatric Research 2024 doi: 10.1038/s41390-024-03197-1
  3. Moreira A, Noronha M, Joy J, Bierwirth N, Tarriela A, Naqvi A, Zoretic S, Jones M, Marotta A, Valadie T, Brick J, Winter C, Porter M, Decker I, Bruschettini M, Ahuja SK. Rates of bronchopulmonary dysplasia in very low birth weight neonates: A systematic review and meta-analysis. Respiratory Research 2024, doi: 10.1186/s12931-024-02850-x 
  4. Bruschettini M, Schmölzer GM, Nai ML, Mitrad S, Davis PG, Soll RF. Lack of blinding may affect objective outcomes in trials on neonatal ventilation. Neonatology 2024; doi: 10.1159/000540604
  5. Ulinder T, Hellström W, Gadsbøll C, Robertz G, Nilsson L, Gebka M, Bruschettini M, Hellström A, Ley D. Fetal haemoglobin and oxygen requirement in preterm infants: an observational study. Archives of Disease in Childhood, 2024 Sep 25:fetalneonatal-2024-327411. doi: 10.1136/archdischild-2024-327411.
  6. Rose C, Geist M, Bruschettini M. Imputing risk ratio from rate data: a tutorial at the intersection of statistics, systematic reviewing, and clinical research. Cochrane Evidence Synthesis and Methods. Accepted for publication, July 2024
  7. Nilsonne G et al. Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed. Journal of Clinical Epidemiology, submitted
  8. Toews M, Minozzi S, Stegeman BH, Cinquini M, Meerpohl JJ, Färnqvist K, Bruschettini M, Toews I. Rating down for publication bias is rare in Cochrane reviews: a cross sectional study. Journal of Clinical Epidemiology, submitted May 2024
  9. Ringsten M, Färnqvist K, Bruschettini M, Johansson M. Inclusion, characteristics and credibility of systematic reviews in doctoral theses: A cross-sectional study of all Medical Faculties in Sweden. BMJ EBM, submitted June 2024
  10. Rose C, Ringsten M. ChatGPT & Risk of bias. In preparation
  11. Magagnoli C, Hasan RB, Susca F, Caratozzolo D, Shcherbatiuk K, Fiander M, Bruschettini M. Devices to improve success of peripheral vascular catheterization in newborn infants. In preparation
  12. Borys F, Färnqvist K, Lorente Sánchez S, Fiander M, Bruschettini M, Sibrecht G. Monitoring of apnea in preterm infants when discontinuing caffeine administration. In preparation
  13. Borys F, Alarcón Garavito G, Osman AA, Fiander M, Russo C, Bruschettini M, Sibrecht G. Strategies for caffeine administration in preterm infants. In preparation
  14. Rogova O, Herzog K, Carolo dos Santos K, Frilund JP, Al-Majdoub M, Bruschettini M, Ley D, Spégel P. Absence of caffeine impact on hepatic metabolism in healthy conditions: Insights from human cross-sectional studies, in vivo and in vitro experiments. In preparation